Skip to main content
Equibles
AKBA $0.87 -0.69%
AKBA logo
AKBA · Akebia Therapeutics, Inc.
Track AKBA — free

Use AKBA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AKBA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.87 -0.01 (-0.69%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$244.05M
Shares
277.11M
Volume · Oct 2 7.11M Avg daily vol (3M) 6.07M
All webcasts

Earnings call · FY2019 Q4

Akebia Therapeutics, Inc. (AKBA) Q4 2019 Earnings Call

Concluded Mar 10, 2020
Mar 10, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $69.56M +16.2% YoY
Net income -$94.48M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 10, 2020 10-K report Filed Mar 12, 2020

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License Collaboration and Other Revenue$40.64M
Product$28.91M
Full-screen source Call document

AKBA transcript alerts

Akebia Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →